Baveno VI-SSM was able to stratify the risk of portal hypertension-related events in patients with HBV-related cirrhosis
DOI:
10.3350/cmh.2024.0609
Publication Date:
2025-02-05T07:43:42Z
AUTHORS (27)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....